Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study - Concepedia

Concepedia

Publication | Closed Access

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

896

Citations

21

References

2018

Year

Ludwig Kappos, Amit Bar‐Or, Bruce Cree, Robert J. Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L. Arnold, Sophie Arnould, Tatiana Scherz,

Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological MonitoringNeurological ProgressNeurologyMultiple SclerosisMedicineNeurological AssessmentNeuroimmunologyHealth Sciences

References

	Year	Citations

Page 1

Page 1